Estudios originales

Published on 21 de octubre de 2021 | http://doi.org/10.5867/medwave.2021.09.8474

Effectiveness of biosimilar drugs in the treatment of renal anemia: A case series

Back to article Figure 2.

Cost reduction using biosimilars (P < 0.001).